ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $108 | -88.4% | 16,145 | -84.8% | 0.00% | -90.9% |
| Q1 2023 | $935 | -3.8% | 105,928 | -16.8% | 0.01% | -21.4% |
| Q4 2022 | $972 | -99.9% | 127,350 | -33.6% | 0.01% | -6.7% |
| Q3 2022 | $1,366,000 | -20.5% | 191,868 | -9.7% | 0.02% | -21.1% |
| Q2 2022 | $1,718,000 | -40.4% | 212,483 | +2.3% | 0.02% | -9.5% |
| Q1 2022 | $2,883,000 | +5.4% | 207,728 | +205.7% | 0.02% | -25.0% |
| Q1 2021 | $2,735,000 | – | 67,955 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |